Want to see INVU full AI Analyst Report?
Investview (INVU) AI Stock Analysis
Investview
(Other OTC:INVU)
INVU scores low primarily due to deteriorating fundamentals (revenue decline, swing to sizable losses, and negative operating/free cash flow), which outweigh the benefit of modest leverage. Technicals remain weak with the stock below longer-term moving averages and a low RSI, while valuation is difficult to support given negative earnings and no dividend yield provided.
Investview (INVU) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $30.43M
- Dividend Yield
- ―
- Average Volume (3M)
- 910.62K
- Price to Earnings (P/E)
- -1.9
- Beta (1Y)
- -0.31
- Revenue Growth
- -48.30%
- EPS Growth
- -718.18%
- Country
- US
- Employees
- 42
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Application
Investview Business Overview & Revenue Model
Company Description
Investview, Inc., operating through its various subsidiaries, offers a comprehensive suite of financial literacy resources, digital asset solutions, and supporting technology platforms primarily for individual users. The firm provides services includ...
How the Company Makes Money
Investview primarily makes money through (1) subscription and membership fees for access to its financial education content, analytical tools, and related services sold to customers and distributed via an independent representative/affiliate network;...
Investview Financial Statement Overview
Summary
Financial performance is weak: the income statement shows a meaningful deterioration in 2025 with revenue down 11.5% and profitability swinging to a sizable loss (net margin ~-24.6%). Cash flow also turned negative (operating and free cash flow), indicating worsening cash generation. The balance sheet is a partial offset with manageable leverage (debt-to-equity ~0.14), but sharply negative returns driven by losses remain a major risk.
Income Statement
34NegativeBalance Sheet
56NeutralCash Flow
42Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2023 | Dec 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.57M | 36.26M | 52.38M | 61.85M | 89.29M | 24.18M |
| Gross Profit | 8.79M | 20.23M | 39.70M | 53.60M | 75.14M | 21.68M |
| EBITDA | -10.83M | -8.26M | 7.22M | 12.18M | -19.90M | -6.68M |
| Net Income | -15.76M | -8.91M | 1.19M | -12.94M | -24.97M | -21.29M |
Balance Sheet | ||||||
| Total Assets | 13.48M | 21.50M | 31.57M | 35.58M | 51.50M | 10.40M |
| Cash, Cash Equivalents and Short-Term Investments | 1.99M | 9.99M | 23.60M | 20.47M | 31.00M | 137.18K |
| Total Debt | 1.22M | 1.28M | 3.44M | 10.72M | 14.02M | 3.79M |
| Total Liabilities | 6.44M | 12.57M | 14.37M | 18.20M | 22.56M | 24.66M |
| Stockholders Equity | 1.59M | 8.92M | 17.19M | 17.37M | -72.92M | -14.26M |
Cash Flow | ||||||
| Free Cash Flow | 7.04M | -3.70M | 7.84M | -5.91M | 30.34M | -620.84K |
| Operating Cash Flow | 11.36M | -3.70M | 8.30M | 9.36M | 32.98M | 4.62M |
| Investing Cash Flow | -5.73M | -4.21M | -1.60M | -14.17M | -2.63M | -5.25M |
| Financing Cash Flow | -2.87M | -4.57M | -5.37M | -6.31M | 711.91K | 624.37K |
Investview Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For INVU, the sentiment is Neutral. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a neutral trend. The MACD of 0.00 indicates Positive momentum. The RSI at 54.68 is Neutral, neither overbought nor oversold. The STOCH value of 233.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for INVU.
Investview Risk Analysis
Investview disclosed 57 risk factors in its most recent earnings report. Investview reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksInvestview Peers Comparison
Overall Rating
NTWK69Neutral
SURG47Neutral
INLX46Neutral
PHUN46Neutral
AWRE44Neutral
INVU42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | $91.80M | 30.61 | 7.84% | ― | 12.53% | -0.08% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 47Neutral | $8.71M | -0.11 | 193.81% | ― | 83.91% | 38.02% | |
| 46Neutral | $18.16M | -6.30 | -26.38% | ― | -5.53% | -56.77% | |
| 46Neutral | $38.27M | -2.88 | -13.83% | ― | 14.63% | 11.10% | |
| 44Neutral | $19.37M | -2.31 | -36.87% | ― | -9.81% | -45.08% | |
| 42Neutral | $31.25M | -1.92 | -194.91% | ― | -48.30% | -718.18% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| INVU | Investview Inc. | 0.02 | -0.01 | -46.67% | |
| AWRE | Aware Inc. | 0.89 | -1.41 | -61.43% | |
| NTWK | Netsol | 7.68 | 3.45 | 81.56% | |
| PHUN | Phunware | 1.87 | -0.58 | -23.67% | |
| INLX | Intellinetics, Inc. | 4.04 | -5.30 | -56.75% | |
| SURG | Surgepays Inc | 0.16 | -2.42 | -93.64% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 01, 2026